NasdaqGM - Nasdaq Real Time Price USD

Neuronetics, Inc. (STIM)

4.2400
+0.0500
+(1.19%)
At close: April 24 at 4:00:00 PM EDT
4.2500
+0.01
+(0.24%)
After hours: April 24 at 7:46:43 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
74,890
74,890
71,348
65,206
55,312
Cost of Revenue
20,729
20,729
19,643
15,483
11,653
Gross Profit
54,161
54,161
51,705
49,723
43,659
Operating Expense
88,724
88,724
82,259
84,834
71,223
Operating Income
-34,563
-34,563
-30,554
-35,111
-27,564
Net Non Operating Interest Income Expense
-7,300
-7,300
-5,400
-4,300
-4,000
Other Income Expense
-1,878
-1,878
5,789
2,203
390
Pretax Income
-43,741
-43,741
-30,165
-37,208
-31,174
Net Income Common Stockholders
-43,708
-43,708
-30,189
-37,159
-31,193
Diluted NI Available to Com Stockholders
-43,708
-43,708
-30,189
-37,159
-31,193
Basic EPS
-1.22
-1.38
-1.05
-1.38
-1.22
Diluted EPS
-1.22
-1.38
-1.05
-1.38
-1.22
Basic Average Shares
29,727.5000
31,734
28,658
26,900
25,479
Diluted Average Shares
29,727.5000
31,734
28,658
26,900
25,479
Total Operating Income as Reported
-34,563
-34,563
-30,554
-35,111
-27,564
Total Expenses
109,453
109,453
101,902
100,317
82,876
Net Income from Continuing & Discontinued Operation
-43,708
-43,708
-30,189
-37,159
-31,193
Normalized Income
-39,281
-39,281
-30,189
-37,159
-31,193
Interest Expense
6,500
6,500
4,800
3,600
3,300
Net Interest Income
-7,300
-7,300
-5,400
-4,300
-4,000
EBIT
-37,241
-37,241
-25,365
-33,608
-27,874
EBITDA
-35,168
-35,168
-23,359
-31,960
-26,814
Reconciled Cost of Revenue
20,729
20,729
19,643
15,483
11,653
Reconciled Depreciation
2,073
2,073
2,006
1,648
1,060
Net Income from Continuing Operation Net Minority Interest
-43,708
-43,708
-30,189
-37,159
-31,193
Total Unusual Items Excluding Goodwill
-4,427
-4,427
--
--
--
Total Unusual Items
-4,427
-4,427
--
--
--
Normalized EBITDA
-30,741
-30,741
-23,359
-31,960
-26,814
12/31/2021 - 6/28/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NOTV Inotiv, Inc.
1.9200
+8.47%
 
XGN Exagen Inc.
5.85
+2.27%
 
CRL Charles River Laboratories International, Inc.
115.76
+6.20%
 
RDNT RadNet, Inc.
50.45
+2.94%
 
WGS GeneDx Holdings Corp.
109.39
+3.50%
 
XWEL XWELL, Inc.
0.8000
+1.27%
 
IQV IQVIA Holdings Inc.
150.68
+2.46%
 
NEOG Neogen Corporation
5.20
+5.69%
 
QGEN Qiagen N.V.
43.06
+1.75%
 
ENZ Enzo Biochem, Inc.
0.3138
-17.77%